Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited…
www.sciencedirect.com
Highlights
•
Ivermectin is an inhibitor of the COVID-19 causative virus (SARS-CoV-2)
in vitro.
•
A single treatment able to effect ~5000-fold reduction in virus at 48 h in cell culture.
•
Ivermectin is FDA-approved for parasitic infections, and therefore has a potential for repurposing.
•
Ivermectin is widely available, due to its inclusion on the WHO model list of essential medicines.